Jul 20, 2026 08:00AM
Jul 20, 2026 08:00AM
Jul 20, 2026 07:01AM
Jul 20, 2026 07:00AM
Jul 1, 2026 07:00AM
Jul 1, 2026 07:00AM
Jun 10, 2026 07:01AM Harrow re-launches VERKAZIA eye drops for pediatric eye condition
Jun 10, 2026 07:00AM
May 11, 2026 04:05PM
Apr 16, 2026 07:00AM
Mar 18, 2026 07:00AM
Mar 3, 2026 07:02AM
Mar 3, 2026 07:00AM
Mar 2, 2026 04:05PM Harrow Announces Q4 and Full-Year 2025 Financial Results and 2026 Financial Guidance
Feb 17, 2026 07:00AM
Feb 4, 2026 06:48AM
Feb 2, 2026 07:02AM
Feb 2, 2026 07:00AM
Nov 18, 2025 07:01AM
Nov 18, 2025 07:00AM
Nov 10, 2025 04:05PM Harrow Announces Third Quarter 2025 Financial Results
Oct 6, 2025 07:00AM
Oct 6, 2025 07:00AM
Sep 26, 2025 07:00AM
Sep 26, 2025 07:00AM
Sep 25, 2025 04:06PM
Sep 25, 2025 04:05PM
Sep 23, 2025 06:45AM Harrow Health (HROW) PT Raised to $70 at B.Riley
Sep 15, 2025 07:00AM
Aug 11, 2025 04:01PM
Jul 17, 2025 07:00AM
Jul 17, 2025 07:00AM
Jun 18, 2025 07:00AM
Jun 9, 2025 07:03AM
Jun 9, 2025 07:00AM Harrow Acquires U.S. Commercial Rights to BYQLOVI™ (Clobetasol Propionate Ophthalmic Suspension) 0.05% from Formosa Pharmaceuticals
May 8, 2025 04:01PM
Apr 10, 2025 07:00AM
Mar 27, 2025 04:01PM
Mar 24, 2025 07:05AM
Mar 24, 2025 07:00AM
Mar 17, 2025 04:01PM
Mar 17, 2025 07:00AM Harrow Launches VEVYE® Access for All
Mar 11, 2025 07:00AM
Jan 27, 2025 07:30AM
Jan 7, 2025 07:01AM
Jan 7, 2025 07:00AM
Nov 21, 2024 07:02AM
Nov 21, 2024 07:00AM
Nov 13, 2024 04:34PM Harrow Announces Third Quarter 2024 Financial Results
Nov 13, 2024 07:00AM

1,171,064 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All